“We expect headline indices to rise, as most of market cap is in stocks linked to rising penetration of products/formalisation, market share gains, or global factors. FY21 EPS growth could still be reasonable at 12-14 per cent (currently 28 per cent); the course of FY22 estimates would drive markets in CY20: this too may settle in low-teens. Narrow market performance should continue at least till mid-year as uncertainty stays high, but we must start reducing concentration risk. We stay overweight financials (SBI, ICICI, ICICI Life), telecom (BRTI), utilities (PGRD) and metals (TATA), minor overweight on pharma (DRRD, LUPN) and IT (TECHM), market weight on staples and underweight discretionary, cement, and industrials,” the report analyses.